только для медицинских специалистов
Консультант врача. Электронная медицинская библиотека

Консультант врача

Электронная медицинская библиотека

Доступ к библиотеке Версия для слабовидящих
Раздел 11 / 11
Страница 1 / 1

Список литературы

  1. Аведисова А.С., Марачев М.П. Клиническая типология атипичной депрессии при биполярном и монополярном аффективном расстройстве // Журнал неврологии и психиатрии им. С.С. Корсакова. 2012. Т. 112. № 3. С. 18–23.
  2. Аведисова А.С. Маниакально-депрессивный психоз — биполярное расстройство — аффективный спектр: смена парадигм // Журнал неврологии и психиатрии им. С.С. Корсакова. 2012. Т. 112. № 11. С. 21–28.
  3. Аведисова А.С., Воробьев Р.В. Эволюция концепции смешанных состояний в клинике биполярного аффективного расстройства // Журнал неврологии и психиатрии им. С.С. Корсакова. 2013. Т. 113. № 6. С. 4–10.
  4. Акжигитов Р.Г., Яковлев А.Ю. К вопросу о диагностике расстройств биполярного спектра // Обозрение психиатрии и медицинской психологии. 2011. Т. 1. С. 41–45.
  5. Александров А.А. Биполярное аффективное расстройство: диагностика, клиника, течение, бремя болезни // Медицинские новости. 2008. № 12. С. 7–12.
  6. Амбрумова А.Г. Индивидуально-психологические аспекты суицидального поведения // Актуальные проблемы суицидологии. Москва, 1978. С. 44–59.
  7. Ашенбреннер Ю.В.,Чумаков Е.М., Петрова Н.Н. Резидуальные симптомы и социальное функционирование у пациентов с биполярным аффективным расстройством в ремиссии // Неврологический вестник. 2019. Т. 51. № 2. С. 66–71.
  8. Беккер Р.А., Быков Ю.В. Ламотриджин в лечении эпилепсии и расстройств биполярного спектра: две основные терапевтические мишени // Психиатрия и психофармакотерапия. 2018. Т. 28. № 2. С. 36–49.
  9. Васюк Л.В. Послеродовые психозы. Часть II // Психиатрия (научно-практический журнал). 2010. № 2. С. 72–82.
  10. Гависова А.А., Твердикова М.А., Балушкина А.А. Климактерический синдром: особенности терапии психоэмоциональных нарушений // Русский медицинский журнал. 2009. Т. 17. № 20. С. 1408–1411.
  11. Гарнизов Т., Хаджиделева Д. Послеродовая депрессия // Вестник по педагогике и психологии Южной Сибири. 2015. № 3. С. 59–70.
  12. Голяновский О.В., Падалко А.А., Мехедко В.В., Хименко М.В. Послеродовые психозы (обзор литературы) // Здоровье женщины. 2015. № 4. С. 57–62.
  13. Жиляева Т.В. Предменструальные расстройства настроения: этиология, патогенез, диагностика и лечение (обзор литературы) // Проблемы репродукции. 2015. № 4. С. 76–85.
  14. Зайдиева Я.З. Новые возможности лечения климактерических расстройств в постменопаузе // Южно-Российский медицинский журнал. 2003. № 2. С. 64–70.
  15. Керимова Н.Р., Юсупова Д. Состояние психического здоровья женщин в послеродовом периоде // Вестник Кыргызско-российского славянского университета. 2007. Т. 7. № 9. С. 96–99.
  16. Колягин В.В. Биполярное аффективное расстройство. Иркутск : РИО ИГМАПО — филиал ФГБОУ ДПО РМАНПО Минздрава России, 2017. 190 с.
  17. Коробкова И.Г. Терапия депрессий при биполярном аффективном расстройстве: дис. … канд. мед. наук. Москва, 2017. 132 с.
  18. Костюкова Е.Г., Мосолов С.Н. Современные подходы к диагностике, лечению и профилактике депрессии при биполярном расстройстве // Социальная и клиническая психиатрия. 2003. Т. 13. № 4. С. 106–114.
  19. Кулиев Р.Т., Руженков В.А. Психические расстройства при нормально протекающей беременности (клиническая структура и лечение) // Тюменский медицинский журнал. 2012. № 1. С. 27–28.
  20. Медведев В.Э., Фролова В.И., Тер-Исраэлян А.Ю. и др. Терапия депрессивных расстройств, протекающих с цирканнуальными ритмами // Психиатрия и психофармакотерапия им. П.Б. Ганнушкина. 2018. Т. 20. № 5. С. 38–43.
  21. Мосолов С.Н., Костюкова Е.Г., Ушкалова А.В. и др. Алгоритмы биологической терапии биполярного аффективного расстройства // Современная терапия психических расстройств. 2013. Т. 4. С. 31–39.
  22. Мосолов С.Н. Биполярное аффективное расстройство. Диагностика и терапия. Москва : МЕДпресс-информ, 2008. 384 с.
  23. Мосолов С.Н., Ушкалова А.В., Костюкова Е.Г. и др. Диагностика биполярного аффективного расстройства II типа среди пациентов с текущим диагнозом рекуррентного депрессивного расстройства // Современная терапия психических расстройств. 2014. Т. 2. С. 2–12.
  24. Мосолов С.Н., Костюкова Е.Г., Ушкалова А.В. Клиника и терапия биполярной депрессии. Москва : АМА-ПРЕСС, 2009. 48 с.
  25. Петрова Н.Н. К вопросу о коморбидности биполярных аффективных и тревожных расстройств // Социальная и клиническая психиатрия. 2016. Т. 26. № 2. С. 106–110.
  26. Прибытков А.А. Клинические особенности депрессивных расстройств невротического уровня в послеродовом периоде // Социальная и клиническая психиатрия. 2005. Т. 4. № 15. С. 63–66.
  27. Саидова Р.А., Алексанян С.Г., Тропынина Е.В. Современные принципы гормональной коррекции нарушений менструальной функции в перименопаузальном периоде // Вопросы гинекологии, акушерства и перинатологии. 2008. Т. 7. № 4. С. 46–52.
  28. Симуткин Г.Г. Особые паттерны течения аффективных расстройств. Томск : Издательство Томского университета, 2010. 416 с.
  29. Сметник В.П., Ткаченко Н.М., Глезер Г.А., Москаленко Н.П. Климактерический синдром. Москва : Медицина, 1988. 288 с.
  30. Сметник В.П., Тумилович Л.Г. Медико-биологические проблемы климактерия и постовариэктомии // Неоперативная гинекология. Москва : МИА, 2003. С. 458–499.
  31. Сметник В.П., Тумилович Л.Г. Неоперативная гинекология. Руководство для врачей. Москва : МИА, 2005. 591 с.
  32. Сметник В.П., Кулаков В.И. Руководство по климактерию. Москва : МИА, 2001. 685 с.
  33. Смулевич А.Б. Депрессии и коморбидные расстройства. Москва, 1997. 154 с.
  34. Смулевич А.Б., Андрющенко А.В., Романов Д.В. и др. Ремиссии при аффективных заболеваниях: эпидемиология, психопатология, клинический и социальный прогноз, вторичная профилактика // Журнал неврологии и психиатрии им. С.С. Корсакова. 2014. Т. 114. № 3. С. 4–13.
  35. Степанов И.Л., Горячева Е.К. Гендерные особенности структуры депрессивного состояния и социального функционирования больных рекуррентным депрессивным и биполярным аффективным расстройствами // Социальная и клиническая психиатрия. 2012. Т. 22. № 1. С. 38–43.
  36. Татарчук Т.Ф., Венцковская И.Б. Современный взгляд на лечение синдрома предменструального напряжения (ПМС) // Медицинская газета «Здоровье Украины». 2004. № 91. С. 1–7.
  37. Тихомиров А.Л., Олейник Ч.Г. Патофизиология климактерия и новые возможности заместительной гормонотерапии у женщин в постменопаузе // Русский медицинский журнал. 2003. Т. 11. № 16. С. 22–26.
  38. Тювина Н.А., Столярова А.Е., Смирнова В.Н. Биполярное аффективное расстройство: гендерные особенности течения и терапии // Журнал неврологии и психиатрии им. С.С. Корсакова. 2019. Т. 119. № 12. С. 162–169.
  39. Тювина Н.А., Балабанова В.В. , Воронина Е.О. Гендерные особенности депрессивных расстройств у женщин // Неврология, нейропсихиатрия и психосоматика. 2015. Т. 7. № 2. С. 75–78.
  40. Тювина Н.А., Столярова А.Е., Морозова В.Д. и др. Гендерные различия в клинической картине депрессии и течении биполярного аффективного расстройства // Неврология, нейропсихиатрия, психосоматика. 2021. Т. 13. № 2. С. 47–56.
  41. Тювина Н.А., Балабанова В.В., Воронина Е.О. Депрессии у женщин, манифестирующие в период климактерия // Журнал неврологии и психиатрии имени С.С. Корсакова. 2017. Т. 117. № 3. С. 22–27.
  42. Тювина Н.А. Депрессия у женщин. Москва : Сервье, 2006. 32 с.
  43. Тювина Н.А. Дифференциальная диагностика и лечение депрессивных расстройств у женщин в период климактерия // Неврология, нейропсихиатрия, психосоматика. 2011. Т. 3. № 1. С. 66–71.
  44. Тювина Н.А. Клиника и терапия предменструальных ухудшений психического состояния у женщин, страдающих психическими заболеваниями: методические рекомендации. Москва, 1982. 31 c.
  45. Тювина Н.А. Клинические особенности предменструального синдрома при основных психических заболеваниях: дис. … канд. мед. наук. Москва, 1983. 231 с.
  46. Тювина Н.А. Особенности лечения депрессивных расстройств у женщин // Журнал психиатрии и психофармакотерапии. 2008. T. 10. № 3. С. 12–16.
  47. Тювина Н.А., Балабанова В.В. Профилактика и лечение психических расстройств климактерического периода // Журнал неврологии и психатрии им. С.С. Корсакова. 1991. № 9. С. 79–82.
  48. Тювина Н.А. Психические нарушения у женщин в период климактерия. Москва : Крон-пресс, 1996. 237 с.
  49. Тювина Н.А., Коробкова И.Г. Сравнительная характеристика клинических особенностей депрессии при биполярном аффективном расстройстве I и II типа // Неврология, нейропсихиатрия, психосоматика. 2016. Т. 8. № 1. С. 22–28.
  50. Тювина Н.А., Коробкова И.Г. Терапия депрессии при биполярном аффективном расстройстве // Неврология, нейропсихиатрия, психосоматика. 2016. Т. 8. № 2. С. 36–43.
  51. Федеральные клинические рекомендации по диагностике и лечению биполярного аффективного расстройства у взрослых (проект) [Электронный ресурс] // РОП. 2013. Режим доступа: https://psychiatr.ru/news/183.
  52. Хроменкова Ю.Ю., Корсак В.О., Капшук Е.А. и др. Психофизиологические предпосылки склонности к депрессии у мужчин и женщин // Бюллетень медицинских интернет-конференций. 2015. Т. 5. № 5. С. 741.
  53. Цукарзи Э.Э., Ильин С.А., Мосолов С.Н. Применение транскраниальной магнитной стимуляции и электросудорожной терапии при терапевтически резистентных депрессиях // Современная терапия психических расстройств. 2015. № 4. С. 25–32.
  54. Юренева С.В., Каменецкая Т.Я. Депрессивные расстройства у женщин в пери- и постменопаузе // Журнал гинекологии. 2007. Т. 9. № 2. С. 5–12.
  55. Abdollahi F., Sazlina S.G., Zain A.M. et al. Postpartum depression and psycho-socio-demographic predictors. Asia-Pacific psychiatry // Off. J. Pacific Rim Coll. Psychiatr. 2014. Vol. 6. N. 4. P. 425–434.
  56. Adams S.S., Eberhard-Gran M., Sabdvik A.R. et al. Mode of delivery and postpartum emotional distress: a cohort study of 55 814 women // BGOG Int. J. Obstet.Gynecol. 2012. Vol. 119. N. 13. P. 305–314.
  57. Addis A., Koren G. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies // Psychol. Med. 2000. N. 30. P. 89–94.
  58. Ahokas A., Kaukoranta J., Wahlbeck K., Alto M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual hisiologic 17 beta-estradiol: a preliminary study // J. Clin. Psychiatry. 2001. Vol. 62. N. 5. P. 332–336.
  59. Akiskal H.S., Benazzi F., Perugi G. et al. Agitated «unipolar» depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy // J. Affect. Dis. 2005. Vol. 85. N. 3. Р. 245–258.
  60. Allilaire J.F., Hantouche E.G., Sechter D. et al. Frequence et aspects cliniques du trouble bipolaire II dans une etude multicentrique francaise: EPIDEP // Encephale. 2001. Vol. 27. P. 149–158.
  61. Altemus M., Neeb C., Davis A. et al. Phenotypic differences between pregnancy-onset and postpartum-onset major depressive disorder // J. Clin. Psychiatry. 2013. Vol. 73. Р. 1485–1491.
  62. Altshuler L., Cohen L., Moline M. et al. The Expert Consensus Guideline Series. Treatment of depression in women // J. Postgrad. Med. 2001.
  63. Altshuler L.L., Kupka R.W., Hellemann G. et al. Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network // Am. J. Psychiatr. 2010. Vol. 167. Р. 708–715.
  64. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. American Psychiatric Publishing, 1994.
  65. Andrea Gogos Luke J., Felmingham Ney Kim L. Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: Are gonadal hormones the link? // Br. J. Pharmacol. 2019. Vol. 176. N. 21. Р. 4119–4135.
  66. Angst J., Gamma A., Benazzi F. et al. Diagnostic issues in bipolar disorder // Eur. Neuropsychopharm. 2003. Vol. 13. Р. 43–50.
  67. Angst J. Switch from depression to mania: a record study over decades between 1920 and 1982 // Psychopathology. 1985. Vol. 18. Р. 140–154.
  68. Arnold L.M. Gender differences in bipolar disorder // Psychiatr. Clin. N. Am. 2003. Vol. 26. N. 3. Р. 595–620.
  69. Azari N.P., Rapoport S.I., Salerno J.A. et al. Interregional correlations of resting cerebral glucose metabolism in old and young women // Brain Res. 1992. Vol. 4. N. 589. Suppl. 2. P. 279–290.
  70. Bach D.R., Behrens T.E., Garrido L. et al. Deep and superficial amygdala nuclei projections revealed in vivo by probabilistic tractography // J. Neurosci. 2011. Vol. 1231. N. 2. P. 618–623.
  71. Bäckström T., Andreen L., Birzniece V. et al. The role of hormones and hormonal treatments in premenstrual syndrome // CNS Drugs. 2003. Vol. 17. N. 5. P. 325–342.
  72. Baldessarini R.J., Vázquez G.H. , Tondo L. Bipolar depression: a major unsolved challenge // Int. J. Bipolar Disord. 2020. Vol. 8. N. 1. Р. 1.
  73. Baldessarini R.J., Tondo L., Pinna N. et al. Suicidal risk factors in major affective disorders // Br. J. Psychiatry. 2019. Vol. 215. N. 4. Р. 621–626.
  74. Baldessarini R.J., Tondo L., Hennen J. Treatment delays in bipolar disorders [Letter] // Am. J. Psychiatry. 1999. Vol. 156. Р. 811–812.
  75. Beardslee W.R., Versage E.M., Gladstone T.R. Children of affectively ill parents: a review of the past 10 years // J. Am. Acad. Child Adolesc. Psychiatry. 1998. Vol. 37. N. 11. P. 1134–1141.
  76. Bebbington P., Dunn G., Jenkins R. et al. The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity // Int. Rev. Psychiatry. 2003. Vol. 15. P. 74–83.
  77. Bennett H.A. Einarson A., Taddio A. et al. Prevalence of depression during pregnancy: systematic review // Obstet. Gynecol. 2004. Vol. 103. N. 4. P. 698–709.
  78. Benute G.R., Nomura R.M., Reis J.S. et al. Depression during pregnancy in women with a medical disorder: risk factors and perinatal outcomes // Clinics (Sao Paulo). 2010. Vol. 65. N. 11. P. 1127–1131.
  79. Bergemann N., Reicher-Rössler A., eds. Estrogen Effects in Psychiatric Disorders. Springer-Verlag, 2005. 291 p.
  80. Bertone-Johnson E.R., Hankinson S.E., Johnson S.R., Manson J.E. Cigarette smoking and the development of premenstrual syndrome // Am. J. Epidemiol. 2008. N. 168. C. 938–945.
  81. Blanco C., Vesga-Lopez O., Stewart J. et al. Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) // J. Clin. Psychiatry. 2012. Vol. 73. P. 224–232.
  82. Bloch M., Schmidt P.J., Danaceau M. et al. Effects of gonadal steroids in women with a history of postpartum depression // Am. J. Psychiatry. 2000. Vol. 157. N. 6. P. 924–930.
  83. Blumenthal S.J. Women and depression // J. Womens Health Gend. Based Med. 1994. N. 3. C. 467–479.
  84. Bodnar L.M., Wisner K.L., Moses-Kolko E. et al. Prepregnancy body mass index, gestational weight gain, and the likelihood of major depressive disorder during pregnancy // J. Clin. Psychiatry. 2009. Vol. 70. P. 1290–1296.
  85. Bolton H., Hughes P., Turton P., Sedgwick P. Incidence and demographic correlates of depressive symptoms during pregnancy in an inner London population // J. Psychosom. Obstet. Gynaecol. 1998. N. 19. P. 202–209.
  86. Boyle C.A., Berkowitz G.S., Kelsey J.L. Epidemiology of premenstrual symptoms // Am. J. Public Health. 1987. Vol. 7. N. 3. P. 349–350.
  87. Brandon A.R., Minhajuddin A., Thase M.E., Jarrett R.B. Impact of Reproductive Status and Age on Response of Depressed Women to Cognitive Therapy // J. Womens Health (Larchmt). 2013. Vol. 22. N. 1. P. 58–66.
  88. Britton J.R. Infant temperament and maternal anxiety and depressed mood in the early postpartum period // Women Health. 2011. Vol. 51. P. 55–71.
  89. Bromberger J.T., Matthews K.A., Schott L.L. et al. Depressive symptoms during the menopausal transition: Study of Women’s Health Across the Nation (SWAN) // J. Affect. Disord. 2007. Vol. 103. P. 267–272.
  90. Bromberger J.T., Schott L.L., Kravitz H.M. et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women’s Health Across the Nation (SWAN) // Arch. Gen. Psychiatry. 2010. Vol. 67. P. 598–607.
  91. Bromberger J.T., Kravitz H.M., Chang Y.F. et al. Major depression during and after the menopausal transition: Study of Women’s Health Across the Nation (SWAN) // Psychol. Med. 2011. Vol. 41. P. 1879–1888.
  92. Cahill L., Haier R.J., White N.S. et al. Sex-related difference in amygdala activity during emotionally influenced memory storage // Neurobiol. Learn. Mem. 2001. Vol. 75. N. 1. P. 1–9.
  93. Cahill L., Uncapher M., Kilpatrick L. et al. Sex-related hemispheric lateralization of amygdala function in emotionally influenced memory: an FMRI investigation // Learn. Mem. 2004. Vol. 11. N. 3. P. 261–266.
  94. Calabrese J.R., Bowden C.L., Sachs G.S. et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group // J. Clin. Psychiatry. 1999. Vol. 60. N. 2. P. 79–88.
  95. Carlson G.A., Finch S.J., Fochtman L.J. et al. Antidepressant-associated switches from depression to mania in severe bipolar disorder // Bipolar Disord. 2007. Vol. 9. Р. 851–859.
  96. Carroll D.G., Kelley K.W. Use of antidepressants for management of hot flashes // Psychopharmacother. 2009. Vol. 29. N. 11. P. 1357–1374.
  97. Chambers C., Johnson K., Dick L. et al. Birth outcomes in pregnant women taking fluoxetine // N. Engl. J. Med. 1996. N. 335. P. 1010–1015.
  98. Chocano-Bedoya P.O., Manson J.E., Hankinson S.E. et al. Dietary B vitamin intake and incident premenstrual syndrome // Am. J. Clin. Nutr. 2011. Vol. 93. N. 5. P. 1080–1086.
  99. Clemente A.S., Diniz B.S., Nicolato R. et al. Bipolar disorder prevalence: a systematic review and meta-analysis of the literature // Braz. J. Psychiatr. 2015. Vol. 37. N. 2. Р. 155–161.
  100. Clout D., Brown R. Sociodemographic, pregnancy, obstetric and postnatal predictors of postpartum stress, anxiety and depression in new mothers // J. Affect. Disord. 2015. Vol. 188. P. 60–68.
  101. Cohen L., Soares C., Otto M. et al. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles // J. Affect. Disord. 2002. Vol. 70. P. 125–132.
  102. Cohen L., Miner C., Brown E. et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries // Obstet. Gynecol. 2002. N. 100. P. 435–444.
  103. Conway C.R., Kumar A., Xiong W. et al. Chronic vagus nerve stimulation significantly improves quality of life in treatment-resistant major depression // J. Clin. Psychiatry. 2018. Vol. 79. N. 5. Р. 52–59.
  104. Coryell W., Endicott J., Maser J.D. et al. Long-term stability of polarity distinctions in the affective disorders // Am. J. Psychiatry. 1995. Vol. 152. Р. 385–390.
  105. Creed F., Dickens Ch. Depression and physical illness. Step Cambridge Univ. Press, 2007. 434 p.
  106. Cripe S.M., Frederick I.O., Qiu C., Williams M.A. Risk of preterm delivery and hypertensive disorders of pregnancy in relation to maternal co-morbid mood and migraine disorders during pregnancy // Paediatr. Perinat. Epidemiol. 2011. Vol. 25. P. 116–123.
  107. Cuijpers P., Munoz R.F. Psychoeducational treatment and prevention of depression: the “coping with depression” course 30 years later // Clin. Psychol. Rev. 2009. N. 29. Р. 449–458.
  108. Cunningham J., Yonkers K.A., O’Brien S., Eriksson E. Update on Research and Treatment of Premenstrual Dysphoric Disorder // Harv. Rev. Psychiatry. 2009. Vol. 17. N. 2. P. 120–137.
  109. Davidson J., Pelton S. Forms of atypical depression and their response to antidepressant drugs // Psychiatry Res. 1986. N. 17. P. 87–95.
  110. de la Cruz M., Syl D., Lai Z. et al. Gender Differences in Health-Related Quality of Life in Patients with Bipolar Disorder // Arch. Womens Ment. Health. 2013. Vol. 16. N. 4. Р. 317–323.
  111. Deakin J.F. Relevance of hormone CNS interactions to psychological changes in the puerperum // Motherhood and Mental Illness: Causes and Cosequences. London : Butterworth, 1989. 132 p.
  112. Deave T., Heron J., Evans J., Emond A. The impact of maternal depression in pregnancy on early child development // BJOG. 2008. Vol. 115. P. 1043–1051.
  113. Dilsaver S.C., Benazzi F., Rihmer Z. et al. Gender, suicidality and bipolar mixed states in adolescents // J. Affect. Disord. 2005. Vol. 87. N. 1. Р. 11–16.
  114. Doree J.P., Des Rosiers J., Lew V. et al. Quetiapine augmentation of treatment-resistant depression: a comparison with lithium // Curr. Med. Res. Opin. 2007. Vol. 23. N. 2. Р. 333–341.
  115. Dunner D.L., Fleiss J.L., Fieve R.R. The course of development of Mania in patients with recurrent depression // Am. J. Psychiatry. 1976. Vol. 133. N. 8. Р. 905–908.
  116. Earley W., Burgess M.V., Rekeda L. et al. Cariprazine treatment of bipolar depression: randomized double-blind placebo-controlled, phase-3 study // Am. J. Psychiatry. 2019. Vol. 176. N. 6. Р. 439–448.
  117. Einstein G. Sex and the Brain: A Reader. Cambridge, MA: MIT Press, 2007.
  118. Endicott J. History, evolution, and diagnosis of premenstrual dysphoric disorder // J. Clin. Psychiatry. 2000. Vol. 61. N. 12. P. 5–8.
  119. Entsuah R., Huang H., Thase M.E. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo // J. Clin. Psychiatry. 2001. N. 62. P. 869–877.
  120. Epperson C., Steiner M , Hartlage S. et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5 // Am. J. Psychiatry. 2012. Vol. 169. P. 465–475.
  121. Ericson A., Kallen B., Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy // Eur. J. Clin. Pharmacol. 1999. N. 55. P. 503–508.
  122. Ernst C., Angst J. The Zurich Study, XII, sex differences in depression: evidence from longitudinal epidemiological data // Eur. Arch. Psychiatr. Clin. Neurosci. 1992. Vol. 241. P. 222–230.
  123. Essex M., Klein M., Miech R., Smider N. Timing of initial exposure to maternal major depression and children’s mental health symptoms in kindergarten // Br. J. Psychiatry. 2001. Vol. 179. P. 151–156.
  124. Ferrari A.J., Baxter A.J., Whiteford H.A. A systematic review of the global distribution and availability of prevalence data for bipolar disorder // J. Affect. Disord. 2011. Vol. 134. Р. 1–13.
  125. Field T. Infants of depressed mothers // Infant Behavior and Deve­lopment, 1995.
  126. Fioretti P., Martini L., Melis G.B. et al. The Menopause: Clinical, Endocrinological and Pathophysiological Aspects. London; New York : Academic Press, 1982.
  127. Flynn H.A., Chermack S.T. Prenatal alcohol use: the role of lifetime problems with alcohol, drugs, depression, and violence // J. Stud. Alcohol Drugs. 2008. Vol. 69. P. 500–509.
  128. Fornaro M., Anastasia A., Novello S. et al. Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis // Bipolar Disord. 2018. Vol. 20. N. 3. Р. 195–227.
  129. Fountoulakis K.N., Vieta E., Sanchez-Moreno J. et al. Treatment guidelines for bipolar disorder: A critical review // J. Affect. Disord. 2005. Vol. 86. Р. 1–10.
  130. Frances A.J., Kahn D.A., Carpenter D. et al. The expert consensus guidelines for treating depression in bipolar disorder // J. Clin. Psychiatry. 1998. Vol. 9. N. 4. Р. 73–79.
  131. Frank E., Carpenter L.L., Kupfer D.J. Sex differences in recurrent depression: are there any that are significant? // Am. J. Psychiatry. 1988. Vol. 145. P. 41–45.
  132. Freeman E., Sammel M., Boorman D., Zhang R. Longitudinal pattern of depressive symptoms around natural menopause // JAMA Psychiatry. 2014. Vol. 71. P. 36–43.
  133. Freeman E., Rickels K., Yonkers K. et al. Venlafaxine in the treatment of premenstrual dysphoric disorder // Obstet. Gynecol. 2001. N. 98. Р. 737–744.
  134. Freeman M.P., Joffe H., Cohen L.S. Postpartum depression: Help patients find the right treatment // Curr. Psychiatry. 2012. Vol. 11. N. 11. P. 14–21.
  135. GBD 2015 Mortality and Causes of Death, Collaborators. (8 October 2016). “Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015” // Lancet. 2016. Vol. 388. N. 10053. P. 1459–1544.
  136. Georgiopoulos A., Bryan T., Yawn B. et al. Population-based screening for postpartum depression // Obstet. Gynecol. 1999. N. 93. P. 653–657.
  137. Gianetto-Berruti A., Feyles V. Premenstrual syndrome // Minerva Gineco­logica. 2002. Vol. 54. N. 2. P. 85–95.
  138. Gijsman H.J., Geddes J.R., Rendell J.M. et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials // Am. J. Psychiatry. 2004. Vol. 161. N. 9. Р. 1537–1547.
  139. Glover V. Maternal depression, anxiety and stress during pregnancy and child outcome; what needs to be done // Best Pract. Res. Clin. Obstet. Gynecol. 2014. Vol. 28. N. 1. P. 25–35.
  140. Gold E.B., Bair Y., Block G. et al. Diet and lifestyle factors associated with premenstrual symptoms in a racially diverse community sample: Study of Women’s Health Across the Nation (SWAN) // Journal of Women’s Health. 2007. Vol. 16. N. 5. P. 641–656.
  141. Goldstein D., Corbin L., K Sundell Effects of first-trimester fluoxetine exposure on the newborn // Obstet. Gynecol. 1997. N. 89. P. 713–718.
  142. Good C.D., Johnsrude I., Ashburner J. et al. Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains // Neuroimage. 2001. Vol. 14. N. 3. P. 685–700.
  143. Goodwin G.M. et al. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology // J. Psychopharmacol. 2016. Vol. 30. N. 6. Р. 495–553.
  144. Gotlib I., Whiffen V., J. Mount et al. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum // J. Cons. Clin. Psychol. 1989. Vol. 57. P. 269–274.
  145. Green S.M., Haber E., McCabe R.E., Soares C.N. Cognitive-behavioural group treatment for menopausal symptoms: a pilot study // Arch. Womens Ment. Health. 2013. Vol. 16. N. 4. P. 325–332.
  146. Gregoire A.J.P., Kumar R., Everitt B. et al. Transdermal estrogen for treatment of severe postnatal depression // Lancet. 1996. N. 347. P. 930–933.
  147. Grote N.K., Bridge J.A., Gavin A.R. et al. A metaanalysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction // Arch. Gen. Psychiatry. 2010. Vol. 67. P. 1012–1024.
  148. Gur E.B., Gokduman A., Turan G.A. et al. Mid-pregnancy vitamin D levels and postpartum depression // Eur. J. Obset. Gynecol. Reprod. Biol. 2014. Vol. 179. P. 110–116.
  149. Gur R.C., Mozley L.H., Mozley P.D. et al. Sex differences in regional cerebral glucose metabolism during a resting state // Science. 1995. Vol. 27. N. 267 (5197). P. 528–551.
  150. Halbreich U., Borenstein J., Pearlstein T., Kahn L.S. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD) // Psychoneuroendocrinology. 2003. Vol. 28. N. 3. P. 3–23.
  151. Halbreich U., Kahn L.S. Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes? // J. Affect. Disord. 2007. Vol. 102. N. 1–3. P. 245–258.
  152. Halbreich U., Bergeron R., Yonkers K. et al. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder // Obstet. Gynecol. 2002. N. 100. P. 1219–1229.
  153. Halbreich U., Rojansky N., Palter S. et al. Estrogen augments serotonergic activity in postmenopausal women // Biol. Psychiatry. 1995. N. 37. P. 434–441.
  154. Haley C., Sung S., Rush A. et al. The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: a STAR*D report // J. Womens Health. 2013. Vol. 22. P. 219–229.
  155. Hamilton J.A., Grant M., Jensvold M.F. Sex and treatment of depression: when does it matter? // In: Psychopharmacology and Women: Sex, Gender, and Hormones. Washington, DC : American Psychiatric Press, 1996. P. 241–257.
  156. Hamilton J.A., Yonkers K.A. Sex differences in pharmacokinetics of psychotropic medications, part I: biological basis for effects // In: Psychopharmacology and Women: Sex, Gender and Hormones. Washington, DC : American Psychiatric Press, 1996. P. 11–42.
  157. Hankin B., Mermelstein R., L. Roesch Sex differences in adolescent depression: Stress exposure and reactivity models // Child Dev. 2007. Vol. 78. P. 279–295.
  158. Harvey A.T., Silkey B.S., Kornstein S.G., Clary C.M. Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status // J. Clin. Psychiatry. 2007. Vol. 68. N. 6. P. 951–958.
  159. Henshaw S. Unintended pregnancy in the United States // Fam. Plan. Perspect. 1998. N. 30. P. 24–29.
  160. Hunter M., Ussher J., Browne S. et al. A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder // J. Psychosom. Obstet. Gynaecol. 2002. N. 23. P. 193–199.
  161. Jahromi M., Zare A., Taghzadeganzadelh M. et al. A study of marital satisfaction among non-depressed and depressed mothers after childbirth in Jahrom, Iran // Global J. Health Sci. 2015. Vol. 7. N. 3. P. 140–143.
  162. Joffe H., Massler А., Sharkey K.M. Evaluation and Management of Sleep Disturbance During the Menopause Transition // Semin. Reprod. Med. 2010. Vol. 28. P. 404–421.
  163. Joffe R.T., MacQueen G.M., Marriott M. et al. A prospective, longitudinal study of percentage of time spent ill in patients with bipolar 1 or bipolar 2 disorders // Bipolar Disord. 2004. Vol. 6. Р. 62–66.
  164. Johnson S. The epidemiology of premenstrual syndrome // Prim. Psychiatry. 2004. Vol. 11. N. 2. P. 27–32.
  165. Johnstone T., van Reekum C.M., Urry H.L. et al. Failure to regulate counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression // J. Neurosci. 2007. Vol. 15. N. 27 (33). P. 877–884.
  166. Jones K., Johnson K.A., Becker J.A. et al. Use of singular value decomposition to characterize age and gender differences in SPECT cerebral perfusion // J. Nucl. Med. 1998. Vol. 39. N. 6. P. 965–973.
  167. Josefsson A., Berg G., Nordin C., Sydsjo G. Prevalence of depressive symptoms in late pregnancy and postpartum // Acta Obstet. Gynecol. Scand. 2001. Vol. 80. P. 251–255.
  168. Kallen B., Olausson P.O. Maternal use of selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn // Pharmacoepidemiol. Drug Safety. 2008. Vol. 17. N. 8. P. 801–806.
  169. Kasper S., Corruble E., Hale A. et al. Antidepressant efficacy of agomelatin versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control // Int. Clin. Psychopharmacol. 2013. N. 28. P. 12–19.
  170. Kaur G., Gonsalves L., Thacker H.L. Premenstrual dysphoric disorder: a review for the treating practitioner // Clev. Clin. J. Med. 2004. Vol. 71. N. 4. P. 303–305.
  171. Kaya Е., Aydemir O., Selcuki D. Residual symptoms in bipolar disorder: The effect of the last episode after remission // Prog. Neuro-psychopharmacol. Biol. Psychiatry. 2007. Vol. 31. N. 7. P. 1387–1392.
  172. Kendall-Tackett K. A new paradigm form depression in new mothers: the central role of inflammation and how breastfeeding and annul-inflammatory treatments protect maternal mental health // J. Affect. Disord. 2015. Vol. 175. P. 34–52.
  173. Kennedy S.H. Treating each and every depressed patient // J. Psychopharmacol. 2008. Vol. 22. N. 7. P. 19–23.
  174. Kessler R.C., Crum R.M., Warner L.A. et al. Lifetime cooccurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey // Arch Gen Psychiatry. 1997. Vol. 54. N. 4. P. 313–321.
  175. Khan A.A., Gardner C.O., Prescott C.A., Kendler K.S. Gender differences in the symptoms of major depression in opposite-sex dizygotic twin pairs // Am. J. Psychiatry. 2002. Vol. 159. N. 8. P. 1427–1429.
  176. Kilbourne A., Cornelius J., Han X. et al. Burden of general medical conditions among individuals with bipolar disorder // Bipolar Disord. 2004. Vol. 6. P. 368–373.
  177. Kilpatrick L.A., Zald D.H., Pardo J.V., Cahill L.F. Sex-related differences in amygdala functional connectivity during resting conditions // Neuroimage. 2006. Vol. 1. N. 30. Suppl. 2. P. 452–461.
  178. Kleinman L. Lowin А., Flood E. et al. Costs of bipolar disorder // Pharmacoeconomics. 2003. Vol. 21. N. 9. Р. 601–622.
  179. Kokras N., Dalla C. Preclinical sex differences in depression and antide­pressant response: implications for clinical research // J. Neurosci. Res. 2017. N. 95. P. 731–736.
  180. Kornstein S.G. Gender differences in depression: implications for treatment // J. Clin. Psychiatry. 1997. Vol. 58. N. 15. P. 12–18.
  181. Kornstein S.G., Schatzberg A.F., Thase M.E. et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression // Am. J. Psychiatry. 2000. N. 157. P. 1445–1452.
  182. Kornstein S.G., Wojcik В.А. Gender effects in the treatment of depression // Psychiatr. Clin. N. Am. Ann. Drug Ther. 2000. N. 7. P. 23–57.
  183. Kornstein S.G., Sloan M.D., Thase M.E. Gender-specific differences in depression and treatment response // Psychopharmacol Bull. 2002. Vol. 36. N. 4. Suppl. 3. P. 99–112.
  184. Koszewska I., Rybakowski J.K. Antidepressant-Induced Mood Conversions in Bipolar Disorder: A Retrospective Study of Tricyclic versus Non-Tricyclic Antidepressant Drugs // Neuropsychobiology. 2009. Vol. 59. N. 1. Р. 12–16.
  185. Koszewska I., Pużyński S. Transition from the depressive stage to the manic stage during the treatment with antidepressive drugs // Psychiatr. Pol. 1991. Vol. 25. Р. 76–82.
  186. Krause D., Jobst A., Kirchberg F. et al. Prenatal immunologic predictors of postpartum depressive symptoms: a prospective study for potential diagnostic markers // Eur. Arch. Psych. Clin. Neurosci. 2014. Vol. 264. N. 7. P. 615–624.
  187. Kronenberg F. Hot flashes: phenomenology, quality of life, and search for treatment options // Ex. Gerontol. 1994. Vol. 29. P. 319–336.
  188. Kurstjens S., Wolke D. Effects of maternal depression on cognitive development of children over the first 7 years of life // J. Child Psychol. Psychiatry. 2001. Vol. 42. P. 623–636.
  189. Lai C.H. Major depressive disorder: gender differences in symptoms, life quality, and sexual function // J. Clin. Psychopharmacol. 2011. Vol. 31. N. 1. P. 39–44.
  190. Laine K., Heikkinen T., Ekblad U., Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations // Arch. Gen. Psychiatry. 2003. N. 60. P. 720–726.
  191. Lawson A., Murphy K.E., Sloan E. et al. The relationship between sleep and postpartum mental disorders. A systematic review. Review // J. Affect. Disord. 2015. Vol. 1. N. 176. P. 65–77.
  192. Lee E.W., Denison F.C., Hor K., Reynolds R.M. Web-based interventions for prevention and treatment of perinatal mood disorders: a systematic review // BMC. 2016. Vol. 16. P. 3–8.
  193. Lee P.J., Liaw J.J., Chen C.M. Concept Analysis of Postpartum Depression // J. Nurs. 2015. Vol. 62. P. 66–71.
  194. Leibenluft E., Charney D.S., Pine D. Researching the pathophysiology of pediatric bipolar disorder // Soc. Biol. Psychiatry. 2003. Vol. 53. Р. 1009–1020.
  195. Levitan R.D., Lesage A., Parikh S.V. et al. Reversed neurovegetative symptoms of depression: a community study of Ontario // Am. J. Psychiatry. 1997. Vol. 154. N. 7. P. 934–940.
  196. Lewis-Hall F.C., Wilson M.G., Tepner R.G., Koke S.C. Fluoxetine vs tricyclic antidepressants in women with major depressive disorder // J. Womens Health. 1997. N. 6. P. 337–343.
  197. Lewitzka U., Severus E., Bauer R. et al. The suicide prevention effect of lithium: more than 20 years of evidence — a narrative review // Int. J. Bipolar. Disord. 2015. Vol. 3. N. 1. Р. 32.
  198. Li D., Liu L., Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study // Hum. Rep. 2009. Vol. 24. N. 1. P. 146–153.
  199. Li Z.J., Matsuda H., Asada T. et al. Gender difference in brain perfusion 99mTc-ECD SPECT in aged healthy volunteers after correction for partial volume effects // Nucl. Med. Comm. 2004. Vol. 25. N. 10. P. 999–1005.
  200. Lin H.-C., Tsai S-Y., Lee H.-C. Increased risk of developing stroke among patients with bipolar disorder after an acute mood episode: A six-year follow-up study // J. Affect. Disord. 2007. Vol. 100. N. 1–3. Р. 49–54.
  201. Ling F.W. Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices // J. Clin. Psychiatry. 2000. Vol. 61. N. 12. P. 9–16.
  202. Logsdon M.C., Wisner K.L., Pinto-Foltz M.D. The impact of peripartum depression on mothering // J. Obstet. Gynecol. Neo Nurs. 2006. Vol. 35. P. 652–658.
  203. Lokuge S., Frey B.N., Foster J.A. et al. Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin // J. Clin. Psychiatry. 2011. Vol. 72. N. 11. P. 1563–1569.
  204. López-Muñoz F., Shen W.W., D’Ocon P. et al. A History of the Pharmacological Treatment of Bipolar Disorder // Int. J. Mol. Sci. 2018. Vol. 19. N. 7. Р. 2143.
  205. Loprinzi C., Kugler J., Sloan J. et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial // Lancet. 2000. N. 356. P. 2059–2063.
  206. Loprinzi C.L., Sloan J.A., Perez E.A. et al. Phase III evaluation of fluoxetine for treatment of hot flashes // J. Clin. Oncol. 2002. N. 20. P. 1578–1583.
  207. MacQueen G.M., Young L.T., Joffe R.T. A review of psychosocial outcome in patients with bipolar disorder // Acta Psychiatr. Scand. 2001. Vol. 103. N. 3. Р. 163–170.
  208. Mahmood T., Roman S., Silverstone T. Prevalence of migraine in bipolar disorder // J. Affect. Disord. 1999. Vol. 52. Р. 239–241.
  209. Makara-Studzinska M.T., Krys-Noszczyk M.K., Jakiel G. Epidemiology of the symptoms of menopause — an intercontinental review // Menopause Rev. 2014. Vol. 13. N. 3. P. 203–211.
  210. Mann J.J., Apter A., Bertolote J. et al. Suicide Prevention Strategies: A Systematic Review // JAMA. 2005. Vol. 294. N. 16. P. 2064–2074.
  211. Marcus S., Kerber K., Rush A. et al. Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study // Compr. Psychiatry. 2008. Vol. 49. P. 238–246.
  212. Marjoribanks J., Brown J., O’Brien P.M., Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome // Cochrane Database Syst. Rev. 2013. Issue 7. P. 83–96.
  213. Marneros A., Akiskal H.S. The overlap of affective and schizophrenic spectra. Cambridge University Press, 2007.
  214. Marsh W.K., Templeton A., Ketter T.A. et al. Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: Preliminary report // J. Psychiatr. Res. 2008. Vol. 42. Р. 247–251.
  215. Marsh W.K., Gershenson B., Rothschild A.J. Symptom severity of bipolar disorder during the menopausal transition // Int. J. Bipolar Disord. 2015. Vol. 3. N. 1. Р. 17.
  216. Martel M. Sexual selection and sex differences in the prevalence of childhood externalizing and adolescent internalizing disorders // Psychol. Bull. 2013. Vol. 139. P. 1221–1259.
  217. Martini J., Petzoldt J., Einsle F. et al. Risk factors and course patterns of anxiety and depressive disorders during pregnancy and after delivery: a prospective-longitudinal study // J. Affect. Disord. 2015. Vol. 175. N. 1. P. 385–395.
  218. Masho S.W., Adera T., South-Paul J. Obesity as a risk factor for premenstrual syndrome // J. Psychosom. Obstet. Gynaecol. 2005. Vol. 26. P. 33–39.
  219. McIntyre R.S., Mancini D.A., McCann S. et al. Topiramate versus bupropion SR when added to mood-stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study // Bipolar Disord. 2002. Vol. 4. N. 3. Р. 207–213.
  220. Miner C., Brown E., McCray S. et al. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial // Clin. Ther. 2002. N. 24. P. 417–433.
  221. Miura S.A., Schapiro M.B., Grady C.L. et al. Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study // J. Neurosci. Res. 1990. Vol. 27. N. 4. P. 500–504.
  222. Moskvina V., Farmer A., Jones I.R. et al. Sex differences in symptom patterns of recurrent major depression in siblings // Depress Anxiety. 2008. Vol. 25. N. 6. P. 527–534.
  223. Nemeroff С. Pharmacotherary of depression and mixed states in bipolar disorder // J. Affect. Disord. 2000. Vol. 59. N. 1. P. 39–56.
  224. Nivoli A.M., Pacchiarotti I., Rosa A.R. et al. Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity // J. Affect. Disord. 2011. Vol. 133. N. 3. Р. 443–449.
  225. Nulman I., Rovet J., Stewart D. et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study // Am. J. Psychiatry. 2002. Vol. 159. P. 1889–1895.
  226. O’Hara M. Depression during pregnancy. Postpartum depression: causes and consequences. New York : Springer-Verlag, 1994. 120 p.
  227. O’Hara M. Social support, life events, and depression during pregnancy and the puerperium // Arch. Gen. Psychiatry. 1986. Vol. 43. P. 569–573.
  228. Oishi A., Mochizuki Y., Otsu R., Inaba N. Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women // Bio PsychoSocial. Med. 2007. N. 1. P. 12–16.
  229. Pande A., Birkett M., Fechner-Bates S. et al.Fluoxetine versus phenelzine in atypical depression // Biol. Psychiatry. 1996. N. 40. P. 1017–1020.
  230. Parial S. Bipolar disorder in women // Indian J. Psychiatry. 2015. Vol. 57. N. 2. Р. 252–263.
  231. Pariser S., Nasrallah H., Gardner D. Postpartum mood disorders: clinical perspectives // J. Womens Health. 1997. Vol. 6. P. 421–434.
  232. Parker G., Spoelma M.J., Tavella G. et al. Categorical differentiation of the unipolar and bipolar disorders // Psychiatry Res. 2021. Vol. 297. 113719.
  233. Parker G., Hegarty B., Granville-Smith I. et al. Is essential fatty acid status in late pregnancy predictive of post-natal depression? // Acta Psychiatr. Scand. 2015. Vol. 131. N. 2. P. 148–156.
  234. Parry B.L. Optimal management of perimenopausal depression // Int. J. Womens Health. 2010. N. 2. P. 143–151.
  235. Patel R., Virani S., Saeed H. et al. Gender Differences and Comorbidities in US Adults with Bipolar Disorder // Brain sci. 2018. Vol. 8. N. 9. Р. 168.
  236. Patten S.B., Wang J.L., Williams J.V. et al. Descriptive epidemiology of major depression in Canada // Can. J. Psychiatry. 2006. Vol. 51. P. 84–90.
  237. Paulson J.F., Keefe H.A., Leiferman J.A. Early parental depression and child language development // J. Child Psychol. Psychiatry. 2009. Vol. 50. P. 254–262.
  238. Paulson J.F., Bazemore S.D. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis // JAMA. 2010. Vol. 303. N. 19. P. 961–969.
  239. Payne J.L. The role of estrogen in mood disorders in women // Int. Rev. Psychiatry. 2003. Vol. 15. N. 3. P. 280–290.
  240. Pearlstein T., Frank E., Rivera-Tovar A. et al. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder // J. Affect. Disord. 1990. N. 20. P. 129–134.
  241. Pearson C., Janz T., Ali J. Mental and substance use disorders in Canada // Health at a Glance. 2013. N. 11. P. 3–12.
  242. Peet M. Induction of mania with serotonin reuptake inhibitors // J. Clin. Psychopharmacol. 1996. Vol. 16. Р. 425–427.
  243. Pelphrey K.A., Carter E.J. Brain mechanisms for social perception: lessons from autism and typical development // Ann. N. Y. Acad. Sci. 2008. Vol. 1145. P. 283–299.
  244. Perich T.A., Roberts G., Frankland A. et al. Clinical characteristics of women with reproductive cycle-associated bipolar disorder symptoms // Austr. N. Zeal. J. Psychiatry. 2017. Vol. 51. N. 2. Р. 161–167.
  245. Peters M. Sex differences in human brain size and the general meaning of differences in brain size // Can. J. Psychol. 1991. Vol. 45. N. 4. P. 507–522.
  246. Physcian’s Desk Reference. Montvale (NJ) : Medical Economics Company, 2000.
  247. Prien R.F., Klett C.J., Caffey E.M. Lithium carbonate and imipramine in the prevention of affective episodes // Arch. Gen. Psychiatry. 1973. Vol. 29. Р. 420–425.
  248. Quitkin F.M., Stewart J.W., McGrath P.J. et al. Columbia atypical depression: a subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo // Br. J. Psychiatry. 1993. N. 21. P. 30–34.
  249. Ragguett R.M., McIntyre R.S. Cariprazine for the treatment of bipolar depression: a review // Exp. Rev. Neurother. 2019. Vol. 19. N. 4. Р. 317–323.
  250. Rajewska-Rager A., Sibilski P., Lepczyńska N. Risk factors for suicide among children and youths with bipolar spectrum and early bipolar disorder // Psychiatr. Pol. 2015. Vol. 49. N. 3. Р. 477–488.
  251. Rapkin A.J., Kuo J. The Premenstrual Syndromes // PMS & PMDD. London : Informa Healthcare, 2007. 183 p.
  252. Rasgon N.L., Bauer M., Glenn T. et al. Menstrual cycle related mood changes in women with bipolar disorder // Bipolar Disord. 2003. Vol. 5. N. 1. Р. 48–52.
  253. Razurel C., Kaiser B. The role of satisfaction with social support on the psychological health of primiparous mothers in the perinatal period // Women & Health. 2015. Vol. 55. N. 2. P. 167–186.
  254. Reis M., Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data // Psychol. Med. 2010. Vol. 40. P. 1723–1733.
  255. Rihmer Z. Suicide risk in mood disorders // Curr. Opin. Psychiatry. 2007. Vol. 20. P. 17–22.
  256. Robinson G.E., Stewart D.E. Postpartum disorders // Psychological Aspects of Women’s Healthcare: The Interface Between Psychiatry and Obstetrics and Gynecology. Washington, DC: American Psychiatric Press, 2001. P. 117–139.
  257. Romans S., Kreindler D., Asllani E. et al. Mood and the menstrual cycle // Psychother. Psychosom. 2013. Vol. 82. N. 1. P. 53–60.
  258. Romans S., Clarkson R., Einstein G. et al. Mood and the menstrual cycle: a review of prospective data studies // Gend. Med. 2012. Vol. 9. N. 5. P. 361–384.
  259. Ross L., Steiner M. A biopsychosocial approach to premenstrual dysphoric disorder // Psychiatr. Clin. N. Am. 2003. N. 26. P. 529–546.
  260. Rossler W., Ajdacic-Gross V., Richer-Rossler A. et al. Are changes during menopause affecting mental health? Results of a prospective long-term Zurich study // World Psychiatry. 2016. Vol. 15. N. 2. P. 146–152.
  261. Roy-Byrne P., Post R.M., Uhde T.W. et al. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH // Acta Psychiatr. Scand. 1985. Vol. 317. Р. 1–34.
  262. Rubinow D.R., Schmidt P.J. Gonadal steroid regulation of mood: the lessons of premenstrual syndrome // Front. Neuroendocrinol. 2006. Vol. 27. N. 2. P. 210–216.
  263. Rubinow D.R. The premenstrual syndrome // JAMA. 1992. Vol. 268. N. 14. P. 1908–1912.
  264. Rudmin F., Ferranda-Nolf M., Skolbekken J.-A. Questions of culture, age, and gender in the epidemiology of suicide // Scand. J. Psychol. 2003. Vol. 44. P. 373–381.
  265. Sachs G. Antidepressants may be useless in bipolar depression. 21st ECNP Congress. Barselona, 2008.
  266. Sachs G.S., Koslov C.L., Ghaemi S.N. The treatment of bipolar depression // Bipolar Disord. Munksgaard. 2000. Vol. 2. Р. 256–260.
  267. Sagud M., Pivac N., Mustapic M. et al. The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression // Psychopharmacology. 2008. Vol. 197. N. 4. Р. 683–685.
  268. Sala R., Goldstein B., Morcillo C. et al. Course of comorbid anxiety disorders among adults with bipolar disorder in the US population // J. Psychiatr. Res. 2012. Vol. 46. P. 865–872.
  269. Salloum N.C., Walker M.C., Gangwani S. et al. Emergence of mania in two middle-aged patients with a history of unipolar, treatment-refractory depression receiving vagus nerve stimulation // Bipolar Disord. 2017. Vol. 19. N. 1. Р. 60–64.
  270. Sasson Y., Chopra M., Harrari E. et al. Bipolar comorbidity: From diagnostic dilemmas to therapeutic challenge // Int. J. Neuropsychopharmacol. 2003. Vol. 6. Р. 139–144.
  271. Saunders E.F., Fitzgerald K.D., Zhang P. et al. Clinical features of bipolar disorder comorbid with anxiety disorders differ between men and women // Depress Anxiety. 2012. Vol. 29. N. 8. Р. 739–746.
  272. Schienle A., Schafer A., Stark R. et al. Gender differences in the processing of disgust- and fear-inducing pictures: an fMRI study // Neuroreport. 2005. Vol. 16. N. 3. P. 277–280.
  273. Schindler B.A. The psychiatric disorders of midlife // Med. Clin. N. Am. 1987. Vol. 71. N. 1. P. 71–85.
  274. Schindler H.P., Utian W.H., Vermeulen A., eds. The Controversial Climacteric. Lancaster, 1981.
  275. Schnatz P.F., Banever A.E., Greene J.F. Menopausal symptoms in clinical population: a pilot study // J. Menopause. 2005. Vol. 12. N. 5. P. 623–629.
  276. Schneider F., Habel U., Kessler C. et al. Gender differences in regional cerebral activity during sadness // Hum. Brain Mapp. 2000. Vol. 9. N. 4. P. 226–238.
  277. Schwartz D.H., Romans S.E., Meiyappan S. et al. The role of ovarian steroid hormones in mood // Horm. Behav. 2012. Vol. 62. N. 4. P. 448–454.
  278. Seeman M.V. Psychopathology in women and men: focus on female hormones // Am. J. Psychiatry. 1997. Vol. 154. N. 12. P. 1641–1647.
  279. Selle V., Schalkwijk S., Vázquez G.H. et al. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium, and second-generation antipsychotics // Pharmacopsychiatry. 2014. Vol. 47. N. 2. Р. 43–52.
  280. Serr D.M., Fioretti P., Martini L. et al., eds. The Menopause: Clinical, Endocrinological and Pathophysiological Aspects. London; New York, 1982.
  281. Sharma V., Xie B., Campbell M.K. et al. A prospective study of diagnostic conversion of major depressive disorder to bipolar disorder in pregnancy and postpartum // Bipolar Disord. 2014. Vol. 16. N. 1. Р. 16–21.
  282. Sher L., Grunebaum M.F., Sullivan G.M. et al. Association of testosterone levels and future suicide attempts in females with bipolar disorder // J. Affect. Disord. 2014. Vol. 166. Р. 98–102.
  283. Sherwin B.B. Estrogenic effects on the central nervous system: clinical aspects // Estrogens and Antiestrogens. Philadelphia : Lippincott-Raven, 1997. P. 75–87.
  284. Silverstein B. Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms // Am. J. Psychiatry. 1999. Vol. 156. N. 3. P. 480–482.
  285. Silverstein B., Edwards T., Gamma A. et al. The role played by depression associated with somatic symptomatology in accounting for the gender difference in the prevalence of depression // Soc. Psychiatry Psychiatr. Epidemiol. 2013. Vol. 48. N. 2. P. 257–263.
  286. Simon G., Cunningham M., Davis R. Outcomes of prenatal antidepressant exposure // Am. J. Psychiatry. 2002. N. 159. P. 2055–2061.
  287. Simoni-Wastila L. Gender and psychotropic drug use // Medical Care. 1998. N. 36. P. 88–94.
  288. Southam E. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats // Eur. J. Pharmacol. 1998. N. 358. Р. 19–24.
  289. Spitzer R. DSM-IV-TR casebook. Washington DC : American Psychiatric Pub., 2002.
  290. Stahl S. Stahl’s essential psychopharmacology. Cambridge : Cambridge University Press, 2008. 31 p.
  291. Stearns V., Isaacs C., Rowland J. et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors // Ann Oncol. 2000. N. 11. P. 17–22.
  292. Stearns V., Beebe K.L., Iyengar M., Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes // JAMA. 2003. N. 289. P. 2827–2834.
  293. Stein A., Gath D., Bucher J. et al. The relationship between postnatal depression and mother-child interaction // Br. J. Psychiatry. 1991. N. 158. P. 46–52.
  294. Steiner M., Wheadon D.E., Kreider M.S., Bushnell W.D. Antidepressant response to paroxetine by gender // 1993 Annual Meeting New Research Program and Abstracts. Washington, DC : American Psychiatric Association, 1990. P. 176.
  295. Stevens J.S., Hamann S. Sex differences in brain activation to emotional stimuli: a meta-analysis of neuroimaging studies // Neuropsychologia. 2012. Vol. 50. N. 7. P. 1578–1593.
  296. Stiskal J., Kulin N., Koren G. et al. Neonatal paroxetine withdrawal syndrome // Arch. Dis. Child Fetal. Neonatal. Educ. 2001. N. 84. P. F134–F135.
  297. Stowe Z., Casarella J., Landry J. Sertraline in the treatment of women with postpartum major depression // J. Clin. Psychiatry. 2001. N. 62. P. 592–596.
  298. Strakowski S.M., Tohen M., Stoll A.L. et al. Comorbidity in mania at first hospitalization // Am. J. Psychiatry. 1992. Vol. 149. Р. 554–556.
  299. Suppes T., Kelly D.I., Perla J.M. Challenges in the management of bipolar depression // J. Clin. Psychiatry. 2005. Vol. 66. N. 5. Р. 11–16.
  300. Suzuki M., Dallaspezia S., Locatelli C. et al. Does early response predict subsequent remission in bipolar depression treated with repeated sleep deprivation combined with light therapy and lithium? // J. Affect. Disord. 2018. Vol. 229. N. 3. Р. 371–376.
  301. Teatero M.L., Mazmanian D., Sharma V. Effects of the menstrual cycle on bipolar disorder // Bipolar Disord. 2014. Vol. 16. N. 1. Р. 22–36.
  302. Thase M.E., Frank E., Kornstein S.G., Yonkers K.A. Gender differences in response to treatments of depression // Gender and Its Effects on Psychopathology. Washington, DC : American Psychiatric Association Press, 2000. P. 103–129.
  303. The World Federation of Societies of Biological Psychiatry (WFSBP). Guidelines for the Biological Treatment of Bipolar Disorders: Acute and longterm treatment of mixed states in bipolar disorder. The world journal of biological psychiatry, 2017.
  304. Tohen M., Calabrese J.R., Vieta E. et al. Effect of comorbid anxiety on treatment response in bipolar depression // J. Affect. Dis. 2007. Vol. 104. P. 137–146.
  305. Tohen M., Vieta E., Calabrese J. et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar depression // Arch. Gen. Psychiatry. 2003. Vol. 60. Р. 1079–1088.
  306. Tondo L., Vázquez G., Baldessarini R.J. Mania associated with antidepressant treatment: comprehensive meta-analytic review // Acta Psychiatr. Scand. 2010. Vol. 121. N. 6. Р. 404–414.
  307. Tondo L., Baldessarini R.J. Rapid Cycling in Women and Men with Bipolar Manic-Depressive Disorders // Am. J. Psychiatry. 1998. Vol. 155. N. 10. Р. 1434–1436.
  308. Toran-Allerand C.D., Singh M., Setalo G.Jr. Novel mechanisms of estrogen action in the brain: new players in an old story // Front. Neuroendocrinol. 1999. Vol. 20. N. 2. P. 97–121.
  309. Travers C., O’Neill S.M., King R. et al. Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status // Climacteric. Vol. 8. P. 56–62.
  310. Tschudin S., Bertea P.C., Zemp E. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample // Arch. Womens Ment. Health. 2010. Vol. 13. N. 6. P. 485–494.
  311. Tseng P.T., Chen Y.W., Tu K.Y. et al. Light therapy in the treatment of patients with bipolar depression: meta-analytic study // Eur. Neuropsychopharmacol. 2016. Vol. 26. N. 6. Р. 1037–1047.
  312. Utian W.H. Consensus on Menopause Research / P.A. van Keep, R.B. Green­blatt, M.A. Albeaux-Fernet, eds. Lancaster, 1976.
  313. Utian W.H. Psychococial and socioeconomic burden of vasomotor symptoms in menopause: A comprehencive review // Health and Qual of Life Outcomes. 2005. Vol. 3. P. 47.
  314. Vieta E., Colom F. Psychoeducation manual for bipolar disorder. Cambridge : Cambridge University Press, 2006.
  315. Viviand-Taylor J., Hickey M. Menopause and depression: is there a link? // Maturitas. 2014. Vol. 79. N. 2. P. 142–146.
  316. Volkow N.D., Wang G.J., Fowler J.S. et al. Gender differences in cerebellar metabolism: test-retest reproducibility // Am. J. Psychiatry. 1997. Vol. 154. N. 1. P. 119–121.
  317. Ware M.R. Fluvoxamine: A review of the controlled trial in depression // J. Clin. Psychiatry. 1997. Vol. 58. N. 5. P. 15–23.
  318. Weiss E.L., Longhurst J.G., Mazure C.M. Childhood sexual abuse as a risk factor for depression in women: Psychosocial and neurobiological correlates // Am. J. Psychiatry. 1999. Vol. 156. N. 6. P. 816–828.
  319. Weissman M.M., Pilowsky D.J., Wickramaratne P.J. et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report // JAMA. Vol. 295. P. 1389–1398.
  320. Wesseloo R., Kamperman A.M., Munk-Olsen T. et al. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: A systematic review and meta-analysis // Am. J. Psychiatry. 2015. Vol. 173. N. 2. Р. 117–127.
  321. Whitehead M., Studd J., eds.The Menopause. Oxford : Blackwell Scientific Publications, 1988.
  322. Wieck A., Kumar R., Hirst A.D. et al. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth // BMJ. 1991. Vol. 14. N. 303 (6803). P. 613–616.
  323. Wikander I., Sundblad C., Andersch B. et al. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? // J. Clin. Psychopharmacol. 1998. N. 18. P. 390–398.
  324. Wisner K., Sit D., McShea M. et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings // JAMA Psychiatry. 2013. Vol. 70. P. 490–498.
  325. Wittchen H.U., Jacobi F., Rehm J. et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010 // Eur. Neuropsychopharmacol. 2011. Vol. 21. P. 655–679.
  326. Woods N.F., Smith-Dijulio K., Percival D.B. et al. Symptoms during the menopausal transition and and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women’s Health Study // J. Women’s Health. 2007. Vol. 16. P. 667–677.
  327. Woolley C.S. Effects of estrogen in the CNS // Curr. Opin. Neurobiol. 1999. Vol. 9. N. 3. P. 349–354.
  328. World Health Organization (WHO). The World Health Report 2001; Mental Health: New Understanding, New Hope. WHO. Geneva, 2001.
  329. Yatham L.N., Kennedy S.H., Parikh S.V. et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 // Bipolar Disord. 2013. Vol. 15. N. 1. Р. 1–44.
  330. Yonkers K. The association between premenstrual dysphoric disorder and other mood disorders // J. Clin. Psychiatry. 1997. Vol. 58, N. 15. P. 19–25.
  331. Young E., Korszun A. Women, stress, and depression: Sex differences in hypothalamic-pituitary-adrenal axis regulation // J. Gend. Specif. Med. 1998. Vol. 1. N. 1. P. 21–27.
  332. Zahn-Waxler C., Shirtcliff E., Marceau K. Disorders of childhood and adolescence: gender and psychopathology // Ann. Rev. Clin. Psychol. 2008. Vol. 4. P. 275–303.
  333. Zimmermann P., Bruckl T., Nocon A. et al. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity // Arch. Gen. Psychiatry. 2009. Vol. 66. P. 1341–1352.
  334. Общая характеристика лекарственного препарата Вальдоксан. Регистрационное удостоверение ЛП-№ (00058)- (РГ-RU) от 25.01.22
  335. Stahl. S.M. (2013). Stahl's essential psychopharmacology: Neuro­scientific basis and practical applications. Cambridge: Cambridge University Press.
  336. Ушкалова А.В. Диагностика и подходы к фармакотерапии депрессивной фазы биполярного аффективного расстройства II типа. Автореферат … дисс. канд. мед. наук. — Москва, 2014. — 28 с.
  337. По материалам: Bazire, Stephen. Psychotropic Drug Directory 2009: The Professionals' Pocket Handbook and Aide Memoire. Quay Books, 2001.

Для продолжения работы требуется вход / регистрация